Diamonds and Dogs


Trio-Tech International (TRT)

Trio-Tech is on fire today, up 21.95% at $4.00. The semi-conductor equipment company saw its shares spike after better than expected earnings. For the fourth quarter, the company announced the revenue increased 10.2% to $9.38 million or $0.07 per share. Both numbers beat last year's numbers of $8.51 million and $0.01 per share, respectively. Gross margin also increased 31% year over year. Shares of Trio-Tech climbed as high as $4.22 intraday but fell shy of their 52-week high of $5.44.

Arrowhead Research Corp. (ARWR)

Arrowhead Research is shooting itself in the foot today, down 47.80% to $6.53. The pharmaceutical company saw its shares fall after disappointing data from their trials. For the companies Hepatitis B trial, ARC-520 was dosed at 2mg/kg and induced a 0.3 log reduction in HBsAG. Investors were expecting a 1.0 log reduction. Arrowhead said that they would continue trials with increased dosage in order to obtain a more robust effect. Shares of Arrowhead hit a new 52-week low of $5.48 intraday.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.